Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Amyloid Dan Protein (1-34) (reduced) trifluoroacetate salt/Amyloid Dan Protein Precursor??? (244-277) (reduced)
Amyloid Dan Protein (1-34) (reduced) trifluoroacetate salt/Amyloid Dan Protein Precursor??? (244-277) (reduced)
CAS No. 1802083-00-6
Amyloid Dan Protein (1-34) (reduced) trifluoroacetate salt/Amyloid Dan Protein Precursor??? (244-277) (reduced)( ——— )
Catalog No. M40782 CAS No. 1802083-00-6
Amyloid Dan Protein (1-34) (reduced) trifluoroacetate salt/Amyloid Dan Protein Precursor (244-277) (reduced)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAmyloid Dan Protein (1-34) (reduced) trifluoroacetate salt/Amyloid Dan Protein Precursor??? (244-277) (reduced)
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmyloid Dan Protein (1-34) (reduced) trifluoroacetate salt/Amyloid Dan Protein Precursor (244-277) (reduced)
-
DescriptionAmyloid Dan Protein (1-34) (reduced) trifluoroacetate salt/Amyloid Dan Protein Precursor (244-277) (reduced)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1802083-00-6
-
Formula Weight4046.6
-
Molecular FormulaC185H270N48O51S2
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Mepivacaine
Mepivacaine
-
Benzoylhypacoitine
Benzoylhypacoitine might be the principal active components which affect mitochondrial growth by Fuzi and its processed products.
-
R 892
Potent and selective bradykinin B1 receptor antagonist (ID50 values are 2.8 and > 600 nM at B1 and B2 receptors respectively). Exhibits no intrinsic agonist activity and is resistant to aminopeptidase and kininase II (ACE) cleavage. Displays hypertensive activity in vivo.
